Upregulation of apolipoprotein l6 improves tumor immunotherapy by inducing immunogenic cell death

HIGHLIGHTS

  • who: Kecheng Liu and colleagues from the The Cancer Center, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China have published the Article: Upregulation of Apolipoprotein L6 Improves Tumor Immunotherapy by Inducing Immunogenic Cell Death, in the Journal: Biomolecules 2023, 13, 415. of 22/02/2023
  • what: The authors explored whether the biomarkers upregulated in EBV-related tumors could further clarify the drivers of ICB therapy response.
  • how: Flow cytometry was conducted using CytoFLEX (Beckman Coulter) and the data were analyzed with CytExpert software (Beckman Brea CA USA). Consistent with the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?